Amy Ma

Amy Ma is an Investment Analyst at BVF PARTNERS, L.P. in San Francisco, where she focuses on fundamental analysis and due diligence of public and select private biotechnology companies, typically within the $50 million to $3 billion market cap range. At BVF, her responsibilities include investment research, financial modeling, and providing strategic assessments to drive decision-making for the fund’s long-term, concentrated portfolio in the biotech sector.

Before joining BVF PARTNERS in 2023, Amy developed her expertise as an Investment Banking Analyst at Centerview Partners, where she worked on mergers, acquisitions, and capital raising for clients in healthcare and related sectors. She began her career as an Investment Banking Summer Analyst at J.P. Morgan, gaining foundational experience in corporate finance and deal execution.

Amy holds a bachelor’s degree in Biological Sciences and Economics from the University of Chicago, where she graduated summa cum laude and was inducted into Phi Beta Kappa. She further distinguished herself as a Dougan Scholar at the Booth School of Business. Amy is particularly recognized for leveraging her interdisciplinary expertise at the intersection of science and business to assess clinical pipeline assets and foster impactful biotech investments.